Effectiveness of chinese herbal medicine as an adjunctive treatment for dilated cardiomyopathy in patients with heart failure

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 10, 2013, Pages 811-819

  Bai, Hongyuan ^a   Li, Yafeng ^a   Han, Ke ^a   Gong, Min ^b   Ma, Aiqun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAWEITONGLUO GRANULE; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUFANGHUANGQISHENGMAIYIN DECOCTION; GINKGO BILOBA LEAVES EXTRACT; HERBACEOUS AGENT; HUANGQI GRANULE; HUANGQIJIANXIN DECOCTION; HUANGQISHENGMAI DECOCTION; JIANXIN DECOCTION; LIUWEIDIHUANG TANG; NUODIKANG CAPSULE; QILIQIANGXIN CAPSULE; SHE XIANG BAO XIN WAN; SHENFU INJ; SHENGMAI INJECTION; SHUXUENING INJECTION; UNCLASSIFIED DRUG; UNINDEXED DRUG; WENXIN GRANULE; WENYANGLISHUIHUOXUEHUAYU DECOCTION; WENYANGYIQIHUOXUELISHUI DECOCTION; XINJIHUOLIYIN DECOCTION; XINYUAN CAPSULE; YIQIFUMAIHUOXUELISHUIFANG DECOCTION; YIXINYIN DECOCTION; ZHENWU DECOCTION; ZHIGANCAOJIAWEIFANG DECOCTION; ZHIGANCAOTANGJIAWE DECOCTIONI;

ARTICLE; CHINESE HERB; CHINESE MEDICINE; CONGESTIVE CARDIOMYOPATHY; DIZZINESS; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC DISCOMFORT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART SIZE; HERBAL MEDICINE; HUMAN; LOW DRUG DOSE; MAXIMUM TOLERATED DOSE; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PLANT LEAF; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; XEROSTOMIA;

CARDIOMYOPATHY, DILATED; DRUGS, CHINESE HERBAL; HEART FAILURE; HUMANS; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 84885698129     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2012.0361     Document Type: Article

References (46)

1. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375:752-762.
2. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
3. Taylor M, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orphanet J Rare Dis 2006;1:27.
4. Towbin J, Lowe A, Colan S, Sleeper L, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-1876.
5. Linde C, Leclercq C, Rex S, Garrigue S, et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.
6. Cleland J, Daubert J, Erdmann E, Freemantle N, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
7. Leclercq C,Walker S, Linde C, Clementy J, et al.comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.
8. Hunt S, Abraham W, Chin M. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53:e1-e90.
9. Richardson P, McKennaW, Bristow M, et al. Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
10. Bao R. Observation on treatment of 34 cases of dilated cardiomyopathy with Chinese and Western medicine. J Pract TCM 2009;25:678-679.
11. Cui T, Ren X, Wang C, Li H. The influence of Wenxin granule on left ventricular remodeling and cardiac function in patients with dilated cardiomyopathy. J Taishan Med Coll 2009;30:768-770.
12. Ding C. Warming yang benefiting qi activating blood and alleviating water retention therapy for dilated cardiomyopathy. J Anhui Tradit Chin Med Coll 2008;27:11-12.
13. Gao J. Clincal study on treating dilated cardiomyopathy with Huangqijianxin Decoction. Wanfang Data: Shandong University of Traditional Chinese Medicine; 2005.
14. Hou J, Xu M, Lan Y, Su L.combination of Chinese traditional and Western medicine for dilated cardiomyopathy: An observation of 31 cases. J Gansu Coll TCM 2007;24:9-11.
15. Jia J, Pang Y. Clinical observation on treatment of Xinyuan Capsules on dilated cardiomyopathy with cardiac dysfunction. J Emerg TCM 2010;19:2015-2043.
16. Liang M, Wang L. Observation on therapeutic effects of Huangqi plus metoprolol on dilated cardiomyopathy with heart failure. Chin Community Doctors 2006;22:39.
17. Lin Z. Analysis on treatment of 40 cases of dilate cardiomyopathy with cardiac dysfunction by Chinese and Western medicine. J Chin TCM Inf 2010;2:218.
18. Liu J, Liu G, Wang T, Liu J. Treatment of Qiliqiangxin capsules on dilated cardiomyopathy with cardiac dysfunction. Clin Med 2008;28:120-121.
19. Liu W, Li Y. Observation on therapeutic effects on treatment of 45 cases of dilated cardiomyopathy with heart failure with Jianxin Decoction. Yunnan J Trad Chin Med Mater Med 2009;30:24-25.
20. Niu T, Li J, Liu P, et al. The effect of granule of eight herbs for clearing out collaterals on BNP in dilated cardiomyopathy. Shanxi J TCM 2010;26:44-46.
21. Peng X.combination of Chinese traditional and western medicine for dilated cardiomyopathy: An observation of 48 cases. Hunan J TCM 2009;25:16-17.
22. Shang F. Observation on therapeutic effects of the combination of Chinese traditional and western medicines on dilated cardiomyopathy. J Emerg TCM 2003;12:300.
23. Shao H, Zhou D. Observation on therapeutic effects of Nuodikang capsules on dilated cardiomyopathy with cardiac dysfunction. Clin Focus 2006;21:1738.
24. Song D, Yang Q, Zheng D, Zeng X. Observation on therapeutic effects of Huangqi combined with atenolol on dilated cardiomyopathy. J Clin Cardiol (China) 2003;19:684-685.
25. Wang R, Duan S, Ma F, Lv Z, et al. Clinical observation of traditional Chinese medicine combined with western medicine on 45 patients with dilated cardiomyopathy. Chin J Basic Med TCM 2004;10:59.
26. Wang Q, Xue J, Yang Z. The clinical study on CHF in patients with dilated cardiomyopathy treated with integrated therapy of TCM and WM. J Emerg TCM 2005;14:917-918.
27. Wang Q. Clinical study on She Xiang Bao Xin Wan in treating dilated cardiomyopathy. Guangming J TCM 2007; 22:57-58.
28. Wang Q, Mo Y, Wei B. Prostecdtive efficacy on ventricular remodeling of zhigancaojiaweifang decoction in treating dilated cardiomyopathy. Chin J Integr Med Cardiovasc/ Cerebrovasc Dis 2008;6:510-512.
29. Wu P, Jiang D, Yin G, et al. Treatment of 45 cases of dilated cardiomyopathy complicated with heart failure and ventricular arrhythmia with Wenxin Granule. Med J Natl Defend Force Southwest China 2010;20:1308-1310.
30. Xia X. Clinical study of Lingguishuganwuwei decoction on treating dilated cardiomyopathy. Wanfang Data: Hubei University of Chinese Medicine; 2006.
31. Yang YZ, Chen RZ, Zhang JN. Observation on collaborative treatment of dilated cardiomyopathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:254-256.
32. Yang H, Duan Y. Clinical observation on treatment of 35 cases of dilated cardiomyopathy with Zhigancaotangjiawei Decoction. Chin J Integr Med Cardiovasc/Cerebrovasc Dis 2008;6:1269-1270.
33. Zhang M, Xu W. Observation on therapeutic effects of Huangqishengmai decoction on dilated cardiomyopathy with heart failure. Hubei J TCM 2010;32:39-40.
34. Zheng G, Li J, Wang J. Clinical study on heart failure of dilated cardiomyopathy treated with statins and Shenfu Injection. Chin J Trad Med Sci Technol 2010;17:482-483.
35. Zhou A, Wu X, Chen W, et al. Clinical observation in treating dilated cardiomyopathy combined with cardiac failure by large dose of astragalus. Zhejiang J TCM 2011;46:26-27.
36. Zhu D, Xu M, Yang J. Observation on therapeutic effects of extract of Ginkgo biloba leaf on dilated cardiomyopathy. Chin J Rural Med Pharm 2008;15:12.
37. Swedberg K. Effects of enalapril on mortality in severe congestive-heart-failure-results of the Cooperative-North- Scandinavian- Enalapril-Survival-Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
38. Lechat P, Brunhuber K, Hofmann R, et al. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
39. Packer M, Bristow M, Cohn J, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
40. Packer M, Coats A, Fowler M, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.
41. Zhao MJ, Wang SR, Li M, et al.comparative study on early application of the recipe for activating blood circulation and the recipe for SUPPL.ementing qi for inhibiting left ventricular remodeling and apoptosis in rats with heart failure. Zhongguo Zhong Yao Za Zhi 2007;32:710-714.
42. Li H, Zhang Y, Ma J. Effects of yiqi huoxue compound combined with exercise therapy on MMP-1 and collagen type III expressions of cardiac muscle in chronic heart failure rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011;31:955-960.
43. Song YH, Cai H, Gu N, et al. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. J Pharm Pharmacol 2011;63:541-549.
44. Gu WL, Chen CX, Wu Q, et al. Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling. Pharmazie 2010;65:770-775.
45. Chen C, Meng Y, Zhang P, et al. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: A study based on Shannon entropy method. Zhong Xi Yi Jie He Xue Bao 2010;8:1080-1084.
46. Zou X, Pan G, Sheng X. Clinical epidemiologic investigation on Chinese medicine syndrome laws in patients with chronic heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011;31:903-908.